Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Enterovirus 71 infection: An experience in Korea, 2009

  • Kim, Kyung-Hyo (Department of Pediatrics, School of Medicine, Ewha Womans University)
  • Received : 2010.04.04
  • Accepted : 2010.04.15
  • Published : 2010.05.15
Download PDF
⟨ Previous Next ⟩

Abstract

Enterovirus 71 (EV71) has been recognized as a frequent cause of epidemics of hand-foot-and-mouth disease (HFMD) associated with severe neurological symptoms. In the spring of 2009, HFMD was epidemic in Korea. Severe cases with complication, including death, have been reported and it has become a public health issue. Most symptomatic EV71 infections commonly result in HFMD or herpangina. These clinical manifestations can be associated with neurologic syndromes frequently. Neurologic syndromes observed in EV71 include meningitis, meningoencephalomyelitis, poliomyelitis-like paralytic disease, Guillain-Barr$\acute{e}$ syndrome, transverse myelitis, cerebellar ataxia, opsoclonus-myoclonus syndrome, benign intracranial hypertension, and brainstem encephalitis. Examinations for EV 71 were performed from the stools, respiratory secretion or CSF of the children by realtime PCR. Gene analysis showed that most of them were caused by EV71 subgenotype C4a which was prevalent in China, 2008. Public health measures including personal and environmental hygiene, must to target daycare centers, kindergartens, and schools where highly susceptible children congregate. To prevent the spread of infection, preschools where transmission persists for more than 2 incubation periods, have been recommended for closure, and trigger criteria for voluntary closure was instituted. During closure, operators are to thoroughly clean the centers before they are allowed to reopen. In addition, parents are advised to ensure that their children adopt a high standard of personal hygiene and to keep the infected child at home until full recovery. Because the outbreaks occur in a cyclical pattern, surveillance system to predict next outbreaks and adequate public health measures to control need to be planned for future. Control of EV71 epidemics through surveillance and public health intervention needs to be maintained in Korea. Future research should focus on understanding of EV71 virulence, identification of the receptor(s) for EV71, development of antiviral agents and development of vaccine.

Keywords

References

  1. Cho HK, Lee H, Kim HS, Seo JW, Lee SH, Kim JH, et al. Hand, Foot and Mouth Diseases Associated with Neurologic Symptoms Related to Enterovirus 71 in Korea, 2009. Korean J Pediatric 2010 in press.
  2. Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 1974;129:304–9. https://doi.org/10.1093/infdis/129.3.304
  3. Abzug MJ. Nonpolio Enteroviruses. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia: WB Saunders Co, 2007:1350-6.
  4. Cardosa MJ, Perera D, Brown BA, Cheon D, Chan HM, Chan KP, et al. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis 2003;9:461-8. https://doi.org/10.3201/eid0904.020395
  5. McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, Cardosa MJ. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol 2001;75:7732-8. https://doi.org/10.1128/JVI.75.16.7732-7738.2001
  6. AbuBakar S, Sam IC, Yusof J, Lim MK, Misbah S, MatRahim N, et al. Enterovirus 71 outbreak, Brunei. Emerg Infect Dis 2009;15:79-82. https://doi.org/10.3201/eid1501.080264
  7. Yang F, Ren L, Xiong Z, Li J, Xiao Y, Zhao R, et al. Enterovirus 71 outbreak in the People's Republic of China in 2008. J Clin Microbiol 2009;47:2351-2.
  8. Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, Wang DY, et al. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol 2009;44:262-7. https://doi.org/10.1016/j.jcv.2009.02.002
  9. Yoke-Fun C, AbuBakar S. Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes. BMC Microbiol 2006;6:74-84. https://doi.org/10.1186/1471-2180-6-74
  10. Jee YM, Cheon DS, Kim K, Cho JH, Chung YS, Lee J, et al. Genetic analysis of the VP1 region of human enterovirus 71 strains isolated in Korea during 2000. Arch Virol 2003;148:1735-46. https://doi.org/10.1007/s00705-003-0133-6
  11. Ortner B, Huang CW, Schmid D, Mutz I, Wewalka G, Allerberger F, et al. Epidemiology of enterovirus types causing neurological disease in Austria 1999-2007: detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes. J Med Virol 2009;81:317-24. https://doi.org/10.1002/jmv.21374
  12. McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 2002;26:91- 107 https://doi.org/10.1111/j.1574-6976.2002.tb00601.x
  13. Ang LW, Koh BK, Chan KP, Chua LT, James L, Goh KT. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann Acad Med Singapore 2009;38:106-12.
  14. Chang LY, Tsao KC, Hsia SH, Shih SR, Huang CG, Chan WK, et al. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA 2004;291:222-7. https://doi.org/10.1001/jama.291.2.222
  15. Chung PW, Huang YC, Chang LY, Lin TY, Ning HC. Duration of enterovirus shedding in stool. J Microbiol Immunol Infect 2001;34:167- 70.
  16. Chang LY, Lin TY, Huang YC, Tsao KC, Shih SR, Kuo ML, et al. Comparison of enterovirus 71 and coxsackievirus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J 1999;18:1092-6. https://doi.org/10.1097/00006454-199912000-00013
  17. Ho M. Enterovirus 71: the virus, its infections and outbreaks. J Microbiol Immunol Infect 2000;33:205-16.
  18. Chang LY, Hsiung CA, Lu CY, Lin TY, Huang FY, Lai YH, et al. Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr Res 2006;60:466-71. https://doi.org/10.1203/01.pdr.0000238247.86041.19
  19. Chang LY, Hsia SH, Wu CT, Huang YC, Lin KL, Fang TY, et al. Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002. Pediatr Infect Dis J 2004;23:327-31. https://doi.org/10.1097/00006454-200404000-00010
  20. Wang SM, Ho TS, Shen CF, Liu CC. Enterovirus 71, One virus and many stories. Pediatr Neonatol 2008;49:113-5. https://doi.org/10.1016/S1875-9572(08)60024-8
  21. Wang SM, Lei HY, Huang KJ, Wu JM, Wang JR, Yu CK, et al. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis 2003;188:564-70. https://doi.org/10.1086/376998
  22. Cherry JD, Krogstad P. Enteroviruses and parechoviruses. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL, editors. Textbook of pediatric infectious diseases. 6th ed. Philadelphia: Elsevier Saunders, 2009:2110-70.
  23. Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologic complications in children with enterovirus 71 infection. N Engl J Med 1999;341:936-42. https://doi.org/10.1056/NEJM199909233411302
  24. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 1999;341:929-35. https://doi.org/10.1056/NEJM199909233411301
  25. McMinn P, Stratov I, Nagarajan L, Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis 2001;32:236- 42. https://doi.org/10.1086/318454
  26. Shimizu H, Utama A, Onnimala N, Li C, Li-Bi Z, Yu-Jie M, et al. Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr Int 2004;46:231-5. https://doi.org/10.1046/j.1442-200x.2004.01868.x
  27. Qiu J. Enterovirus 71 infection: a new threat to global public health? Lancet Neurol 2008;7:868-9. https://doi.org/10.1016/S1474-4422(08)70207-2
  28. Chan KP, Goh KT, Chong CY, Teo ES, Lau G, Ling AE. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis 2003;9:78-85. https://doi.org/10.3201/eid0901.020112
  29. Sarawak Health Department/Ministry of Health Malaysia. Hand, foot and mouth disease [cited 2008 Sep1]. Available from: URL:// http:// www.sarawak.health.gov.my/hfmd.htm#INFO9
  30. Lin TY, Twu SJ, Ho MS, Chang LY, Lee CY. Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg Infect Dis 2003;9:291-3. https://doi.org/10.3201/eid0903.020285
  31. Chong CY, Chan KP, Shah VA, Ng WY, Lau G, Teo TE, et al. Hand, foot and mouth disease in Singapore: a comparison of fatal and non-fatal cases. Acta Paediatr 2003;92:1163-9. https://doi.org/10.1111/j.1651-2227.2003.tb02478.x
  32. Ooi MH, Wong SC, Mohan A, Podin Y, Perera D, Clear D, et al. Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak. BMC Infect Dis 2009;9:3. https://doi.org/10.1186/1471-2334-9-3
  33. Shindarov LM, Chumakov MP, Voroshilova MK, Bojinov S, Vasilenko SM, Iordanov I, et al. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J Hyg Epidemiol Microbiol Immunol 1979;23:284-95.
  34. Nagy G, Takátsy S, Kukán E, Mihály I, Dömök I. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch Virol 1982;71:217-27. https://doi.org/10.1007/BF01314873
  35. Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, Alexander JP, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis 2000;31:678-83. https://doi.org/10.1086/314032
  36. Wang SM, Liu CC. Enterovirus 71: epidemiology, pathogenesis and management. Expert Rev Anti Infect Ther 2009;7:735-42. https://doi.org/10.1586/eri.09.45
  37. Wang SM, Lei HY, Huang MC, Su LY, Lin HC, Yu CK, et al. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J Clin Virol 2006;37:47-52.

Cited by

  1. Comparative Analysis of the Immunogenicity and Protective Effects of Inactivated EV71 Vaccines in Mice vol.7, pp.9, 2012, https://doi.org/10.1371/journal.pone.0046043
  2. Excessive proinflammatory cytokine and chemokine responses of human monocyte-derived macrophages to enterovirus 71 infection vol.12, pp.None, 2010, https://doi.org/10.1186/1471-2334-12-224
  3. Progress on the research and development of human enterovirus 71 (EV71) vaccines vol.7, pp.1, 2010, https://doi.org/10.1007/s11684-012-0237-z
  4. Complete genome sequencing and analysis of six enterovirus 71 strains with different clinical phenotypes vol.10, pp.1, 2013, https://doi.org/10.1186/1743-422x-10-115
  5. Human rhinoviruses and enteroviruses in influenza-like illness in Latin America vol.10, pp.1, 2010, https://doi.org/10.1186/1743-422x-10-305
  6. Epidemiology and Clinical Characteristics of Enterovirus Infections in Children: A Single Center Analysis from 2006 to 2010 vol.20, pp.2, 2010, https://doi.org/10.14776/kjpid.2013.20.2.81
  7. A Case of Myocarditis Following Neonatal Meningitis Caused by Coxsackievirus B1 in Spite of Intravenous Immunoglobulin Treatment vol.60, pp.2, 2010, https://doi.org/10.1093/tropej/fmt086
  8. Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials vol.13, pp.5, 2010, https://doi.org/10.1586/14760584.2014.897617
  9. Performance of reversed transcription loop-mediated isothermal amplification technique detecting EV71: A systematic review with meta-analysis vol.8, pp.2, 2010, https://doi.org/10.5582/bst.8.75
  10. Co-Circulation and Genomic Recombination of Coxsackievirus A16 and Enterovirus 71 during a Large Outbreak of Hand, Foot, and Mouth Disease in Central China vol.9, pp.4, 2010, https://doi.org/10.1371/journal.pone.0096051
  11. Ocular Pathology : Role of Emerging Viruses in the Asia-Pacific Region-A Review vol.3, pp.5, 2010, https://doi.org/10.1097/apo.0000000000000021
  12. Cytokine responses and correlations thereof with clinical profiles in children with enterovirus 71 infections vol.15, pp.None, 2010, https://doi.org/10.1186/s12879-015-0965-1
  13. Validation and utilization of an internally controlled multiplex Real-time RT-PCR assay for simultaneous detection of enteroviruses and enterovirus A71 associated with hand foot and mouth disease vol.12, pp.1, 2015, https://doi.org/10.1186/s12985-015-0316-2
  14. Hand, Foot and Mouth Disease in Yunnan Province, China, 2008-2010 vol.27, pp.2, 2010, https://doi.org/10.1177/1010539511430523
  15. Massive pulmonary hemorrhage in enterovirus 71-infected hand, foot, and mouth disease vol.58, pp.3, 2010, https://doi.org/10.3345/kjp.2015.58.3.112
  16. Important roles of public playgrounds in the transmission of hand, foot, and mouth disease vol.143, pp.7, 2010, https://doi.org/10.1017/s0950268814002301
  17. Children’s Caregivers and Public Playgrounds: Potential Reservoirs of Infection of Hand-foot-and-mouth Disease vol.6, pp.None, 2010, https://doi.org/10.1038/srep36375
  18. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD) vol.15, pp.5, 2016, https://doi.org/10.1586/14760584.2016.1138862
  19. Increased Intracranial Pressure in the Setting of Enterovirus and Other Viral Meningitides vol.2017, pp.None, 2010, https://doi.org/10.1155/2017/2854043
  20. Immunopathogenesis and Virus–Host Interactions of Enterovirus 71 in Patients with Hand, Foot and Mouth Disease vol.8, pp.None, 2010, https://doi.org/10.3389/fmicb.2017.02249
  21. An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice vol.12, pp.5, 2010, https://doi.org/10.1371/journal.pone.0178259
  22. Multifactorial analysis of opsoclonus‐myoclonus syndrome etiology (“Tumor” vs. “No tumor”) in a cohort of 356 US children vol.65, pp.8, 2010, https://doi.org/10.1002/pbc.27097
  23. Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy vol.13, pp.5, 2010, https://doi.org/10.3390/v13050720